- Home
- PMN vs CASI Comparison
PMN vs CASI Comparison
Compare PMN & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMN | CASI |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5M | 24.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PMN | CASI |
|---|---|---|
| Price | $7.23 | $0.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $72.67 | $4.00 |
| AVG Volume (30 Days) | 31.5K | ★ 34.8K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $6.27 | $0.75 |
| 52 Week High | $39.75 | $3.47 |
Technical Indicators
Market Signals| Indicator | PMN | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 29.44 |
| Support Level | $8.00 | $0.83 |
| Resistance Level | $8.73 | $0.95 |
| Average True Range (ATR) | 0.56 | 0.08 |
| MACD | -0.39 | 0.01 |
| Stochastic Oscillator | 9.86 | 7.28 |
Price Performance
Historical ComparisonAbout PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.